# FDA Inspection 1265346 - Recipharm Strangnas AB - November 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/recipharm-strangnas-ab/6c69f219-dca6-4369-b25b-53f10ebb6578
Source feed: FDA_Inspections

> FDA Inspection 1265346 for Recipharm Strangnas AB on November 18, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265346
- Company Name: Recipharm Strangnas AB
- Inspection Date: 2022-11-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1173099 - 2019-05-16](https://www.keypedia.com/records/fda_inspections/recipharm-strangnas-ab/92ee449a-9633-4561-9989-f57065fa07f7)

Company: https://www.keypedia.com/companies/recipharm-strangnas-ab/ee3a0733-8b2e-40e5-b611-fc4098625398

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c